Masimo may decide to separate its consumer business with a traditional spinoff, which involves distributing shares of the new ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. The medtech has tapped Katie Szyman for the role, who has been serving as the worldwide ...

In late 2023, Apple received a small blow to its lucrative Christmas sales period thanks to the medical device manufacturer ...

Interim CEO Michelle Brennan, who was backed by the activist investor, was appointed chairman of Masimo's board, and Politan founder Quentin Koffey was named the vice-chairman. The new ...

Masimo Corp., an Irvine-based medical device maker amid an ... Peter’s work has been featured in prestigious publications such as The New York Times and The Washington Post, and he has appeared on CNN ...

which resulted in a temporary injunction on the sale of some of the range towards the end of last year and subsequent removal of the blood oxygen measurement tech on new devices. Masimo sells a ...

$80,000 of MASIMO CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Support of legislation to mandate ...

Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical ... track record of accelerating revenue growth by bringing new patient monitoring ...

Masimo (NASDAQ:MASI) is a global medical technology ... Nasdaq Stockholm Main Market (SEZI), with cross-trading on the New York OTCQX market (SNZZF). More information is available at senzime.com.